Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor‐β‐mediated growth inhibition
- 7 April 2011
- journal article
- research article
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 24 (3) , 512-524
Abstract
Summary: Melanoma cells are resistant to transforming growth factor‐β (TGFβ)‐induced cell‐cycle arrest. In this study, we investigated a mechanism of resistance involving a regulatory domain, called linker region, in Smad2 and Smad3, main downstream effectors of TGFβ. Melanoma cells in culture and tumor samples exhibited constitutive Smad2 and Smad3 linker phosphorylation. Treatment of melanoma cells with the MEK1/2 inhibitor, U0126, or the two pan‐CDK and GSK3 inhibitors, Flavopiridol and R547, resulted in decreased linker phosphorylation of Smad2 and Smad3. Overexpression of the linker phosphorylation‐resistant Smad3 EPSM mutant in melanoma cells resulted in an increase in expression of p15INK4B and p21WAF1, as compared with cells transfected with wild‐type (WT) Smad3. In addition, the cell numbers of EPSM Smad3‐expressing melanoma cells were significantly reduced compared with WT Smad3‐expressing cells. These results suggest that the linker phosphorylation of Smad3 contributes to the resistance of melanoma cells to TGFβ‐mediated growth inhibition.Keywords
This publication has 56 references indexed in Scilit:
- Pin1 Promotes Transforming Growth Factor-β-induced Migration and InvasionJournal of Biological Chemistry, 2010
- Ubiquitin Ligase Nedd4L Targets Activated Smad2/3 to Limit TGF-β SignalingMolecular Cell, 2009
- Nuclear CDKs Drive Smad Transcriptional Activation and Turnover in BMP and TGF-β PathwaysCell, 2009
- A Negative Feedback Control of Transforming Growth Factor-β Signaling by Glycogen Synthase Kinase 3-mediated Smad3 Linker Phosphorylation at Ser-204Journal of Biological Chemistry, 2009
- Transforming Growth Factor-β-inducible Phosphorylation of Smad3Journal of Biological Chemistry, 2009
- Non-Smad pathways in TGF-β signalingCell Research, 2008
- To (TGF)β or not to (TGF)β: Fine-tuning of Smad signaling via post-translational modificationsCellular Signalling, 2008
- TGFβ in CancerCell, 2008
- The selectivity of protein kinase inhibitors: a further updateBiochemical Journal, 2007
- Rewired ERK-JNK Signaling Pathways in MelanomaCancer Cell, 2007